Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
92396027 | 9239602 | 7 | F | 2002 | 20160805 | 20130418 | 20160810 | EXP | US-009507513-1304USA008275 | MERCK | 0.00 | M | Y | 86.35000 | KG | 20160810 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
92396027 | 9239602 | 1 | PS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG, QD | U | 20788 | 1 | MG | FILM-COATED TABLET | QD | |||||
92396027 | 9239602 | 2 | SS | PROPECIA | FINASTERIDE | 1 | U | 20788 | FILM-COATED TABLET | ||||||||||
92396027 | 9239602 | 3 | SS | FINASTERIDE. | FINASTERIDE | 1 | Oral | 1 MG, UNK | 0 | 1 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
92396027 | 9239602 | 1 | Alopecia |
92396027 | 9239602 | 2 | Androgenetic alopecia |
92396027 | 9239602 | 3 | Androgenetic alopecia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
92396027 | 9239602 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
92396027 | 9239602 | Abdominal pain | |
92396027 | 9239602 | Abnormal loss of weight | |
92396027 | 9239602 | Adverse event | |
92396027 | 9239602 | Anxiety | |
92396027 | 9239602 | Blood iron increased | |
92396027 | 9239602 | Blood testosterone decreased | |
92396027 | 9239602 | Cataract | |
92396027 | 9239602 | Chest pain | |
92396027 | 9239602 | Chromaturia | |
92396027 | 9239602 | Chronic obstructive pulmonary disease | |
92396027 | 9239602 | Cognitive disorder | |
92396027 | 9239602 | Decreased appetite | |
92396027 | 9239602 | Decreased interest | |
92396027 | 9239602 | Depression | |
92396027 | 9239602 | Erectile dysfunction | |
92396027 | 9239602 | Fatigue | |
92396027 | 9239602 | Flushing | |
92396027 | 9239602 | Gastrooesophageal reflux disease | |
92396027 | 9239602 | Haemochromatosis | |
92396027 | 9239602 | Headache | |
92396027 | 9239602 | Hypercholesterolaemia | |
92396027 | 9239602 | Hypertensive heart disease | |
92396027 | 9239602 | Insomnia | |
92396027 | 9239602 | Libido decreased | |
92396027 | 9239602 | Lipoma | |
92396027 | 9239602 | Mycobacterium tuberculosis complex test positive | |
92396027 | 9239602 | Pain in extremity | |
92396027 | 9239602 | Paraesthesia | |
92396027 | 9239602 | Polycythaemia | |
92396027 | 9239602 | Rotator cuff syndrome | |
92396027 | 9239602 | Sexual dysfunction | |
92396027 | 9239602 | Shoulder operation | |
92396027 | 9239602 | Spinal pain | |
92396027 | 9239602 | Tendonitis | |
92396027 | 9239602 | Urinary tract disorder | |
92396027 | 9239602 | Vision blurred | |
92396027 | 9239602 | Visual impairment | |
92396027 | 9239602 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
92396027 | 9239602 | 1 | 1999 | 20140825 | 0 | |
92396027 | 9239602 | 3 | 20130210 | 20160714 | 0 |